Kezdőlap › Gyomorrák › Massachusetts › Boston
Gyomorrák klinikai vizsgálatok: Boston, MA
32 Gyomorrák vizsgálat keres résztvevőket Boston és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Toborzás folyamatban2. fázis
- Dana-Farber Cancer Institute - Oncology Department, Boston
Distance-Based Exercise to Preserve Function and Prevent Disability
Toborzás folyamatban
- Dana-Farber Cancer Institute, Boston
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Toborzás folyamatban1. fázis
- Dana Farber Cancer Institute, Boston
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Toborzás folyamatban1. fázis
- Massachusetts General Hospital, Boston
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
Toborzás folyamatban3. fázis
- Dana Farber Cancer Institute, Boston
IKS014 in Advanced Solid Tumors That Express HER2
Toborzás folyamatban1. fázis
- Dana Farber Cancer Institute, Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Toborzás folyamatban1/2. fázis
- Tufts Medical Center, Boston
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Toborzás folyamatban1. fázis
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Toborzás folyamatban1. fázis
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Toborzás folyamatban1/2. fázis
- Dana Farber Cancer Institute, Boston
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Toborzás folyamatban3. fázis
- Massachusetts General Hospital, Boston
Resilience and Equity in Aging, Cancer, and Health (REACH)
Toborzás folyamatban
- Dana-Farber Cancer Institute, Boston
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Toborzás folyamatban1. fázis
- Dana Farber Cancer Institute, Boston
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Toborzás folyamatban3. fázis
- Research Site, Boston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Toborzás folyamatban1. fázis
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Toborzás folyamatban1/2. fázis
- Dana Farber Cancer Institute, Boston
- Massachusetts General Hospital, Boston
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
Toborzás folyamatban2. fázis
- Massachusetts General Hospital, Boston
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Toborzás folyamatban1. fázis
- Mass General Cancer Center, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Toborzás folyamatban1/2. fázis
- Massachusetts General Hospital Cancer Center, Boston
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Toborzás folyamatban3. fázis
- Tufts Medical Center, Boston
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Toborzás folyamatban1/2. fázis
- Massachusetts General Hospital - Dana Farber, Boston
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Toborzás folyamatban1. fázis
- Beth Israel Deaconess Medical Center, Boston
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Toborzás folyamatban1. fázis
- Massachusetts General Hospital, Boston
- Brigham & Women's Hospital, Boston
- Beth Israel Deaconess Medical Center,East Campus Research Pharmacy, Boston
- és további 2
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Toborzás folyamatbanMegfigyeléses tanulmány
- Dana-Farber Cancer Institute, Boston
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
Toborzás folyamatban2. fázis
- I-Mab Site 1002, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Toborzás folyamatban1/2. fázis
- Massachusetts General Hospital, Boston
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Toborzás folyamatban1/2. fázis
- Massachusetts General Hospital, Boston
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Toborzás folyamatban1. fázis
- Mass General Hospital, Boston
CONFIRM: Magnetic Resonance Guided Radiation Therapy
Toborzás folyamatban
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Toborzás folyamatban1/2. fázis
- Massachusetts General Hospital, Boston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Toborzás folyamatban1/2. fázis
- Dana Farber Cancer Institute, Boston
Comprehensive Outcomes for After Cancer Health
Toborzás folyamatbanEgészséges önkéntesek is jelentkezhetnek
- Dana Farber Cancer Institute, Boston
Gyomorrák vizsgálatok más városokban
- Houston, TX42 tanulmány
- New York City, NY31 tanulmány
- Nashville, TN28 tanulmány
- Baldwin Park, CA22 tanulmány
- Los Angeles, CA22 tanulmány
- Arlington, VA20 tanulmány
- Dallas, TX19 tanulmány
- San Antonio, TX19 tanulmány
- St. Louis, MO18 tanulmány
- Grand Rapids, MI18 tanulmány
- Washington, DC16 tanulmány
- Chicago, IL16 tanulmány
Egyéb vizsgálatok: Boston
- Mellrák112 tanulmány
- Nem kis sejtes tüdőrák90 tanulmány
- Rák (minden típus)85 tanulmány
- Áttétes rák63 tanulmány
- Kolorektális rák63 tanulmány
- Tüdőrák62 tanulmány
- Petefészekrák61 tanulmány
- Prosztatarák59 tanulmány
- Depresszió52 tanulmány
- Endometriális rák50 tanulmány
- Szívelégtelenség44 tanulmány
- Akut mieloid leukémia44 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 6.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.